Genomic Collaboration and Licensing Deals 2018-2025

Genomic Collaboration and Licensing Deals provides the reader with the following key benefits:

•    Understand deal trends since 2018
•    Browse genomic collaboration and licensing deals
•    Benchmark analysis – identify market value of transactions
•    Financials terms - upfront, milestone, royalties
•    Directory of deals by company A-Z, deal type and therapy area
•    Leading deals by value
•    Most active dealmakers
•    Identify assets and deal terms for each transaction
•    Access contract documents - insights into deal structures
•    Due diligence - assess suitability of your proposed deal terms for partner companies
•    Save hundreds of hours of research time

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in genomic dealmaking
2.1. Introduction
2.2. Genomic deals over the years
2.3. Most active genomic dealmakers
2.4. Genomic deals by deal type
2.5. Genomic deals by therapy area
2.6. Genomic deals by industry sector
2.7. Deal terms for genomic deals
2.7.1 Genomic deals headline values
2.7.2 Genomic deal upfront payments
2.7.3 Genomic deal milestone payments
2.7.4 Genomic royalty rates

Chapter 3 – Leading genomic deals
3.1. Introduction
3.2. Top genomic deals by value

Chapter 4 – Most active genomic dealmakers
4.1. Introduction
4.2. Most active genomic dealmakers
4.3. Most active genomic deals company profiles

Chapter 5 – Genomic contracts dealmaking directory
5.1. Introduction
5.2. Genomic contracts dealmaking directory

Chapter 6 – Genomic dealmaking by technology type

Deal directory

Deal directory – Genomic deals by company A-Z
Deal directory – Genomic deals by deal type
Deal directory – Genomic deals by therapy area

Deal type definitions

About Biopharma Research Ltd
Current Partnering
Current Agreements
Recent report titles from Current Partnering

 
Table of figures

Figure 1: Genomic deals since 2018
Figure 2: Active genomic dealmaking activity – 2018 - 2025
Figure 3: Genomic deals by deal type since 2018
Figure 4: Genomic deals by therapy area since 2018
Figure 5: Genomic deals by industry sector since 2018
Figure 6: Genomic deals with a headline value
Figure 7: Genomic deals with an upfront value
Figure 8: Genomic deals with a milestone value
Figure 9: Genomic deals with a royalty rate value
Figure 10: Top genomic deals by value since 2018
Figure 11: Most active genomic dealmakers 2018 - 2025
Figure 12: Genomic deals by technology type since 2018

Pricing options

• $3,995: single-user (encrypted file - one user/device)
• $5,995: multi-user (encrypted file - up to 5 users/devices)
• $7,995: company (unencrypted file)

Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin3 PDF Reader will be provided at report delivery.

Company license files are not encrypted and can be accessed using a PDF Reader.

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

1CellBiO, 2bPrecise, 2seventy bio, 4baseCare, 4bases, 10X Genomics, 22nd Century, A*STAR Bioinformatics Institute, Abbvie, AbCellera Biologics, ABL Diagnostics, Accelerated Cure Project for MS, Accelerate Technologies, AccessDx Laboratory, Access to Comprehensive Genomic Profiling Coalition, AccuGenomics, AccuStem Sciences, Acerta Pharma, Acrobat Genomics, Active Motif, Adaptive Biotechnologies, Adrestia, Advanced Biological Laboratories, AgBiome, Agendia, Agilent Technologies, Agribody Technologies, Agriplex Genomics, AiLife Diagnostics, Akadeum Life Sciences, Akoya Biosciences, Alexion Pharmaceuticals, Alloy Therapeutics, Almac Diagnostics, Almaden Genomics, Alnylam Pharmaceuticals, Amazon Web Services, Ambry Genetics, American Skin Association, Amgen, Amoy Diagnostics, Analytical BioSciences, AnchorDx, Apollomics, Applied Biosystems, Applied Cells, Aptorum Group, Arbor Biotechnologies, ArcherDX, ARCHIMEDlife, Ares Genetics, Arima Genomics, Asa Ren, Assistance Publique-Hôpitaux de Paris, Associazione Poic e Dintorni APS, AstraZeneca, AtlasXomics, Australian Genome Research Facility, Avance Biosciences, Basepair, Battelle, Bayer, Bayer CropScience, Baylor College of Medicine, Baylor Genetics, BC Platforms, Beckman Coulter, Becton Dickinson, Beijing Genomics Institute (BGI), Benson Hill Biosystems, Berkeley Lights, Berry Genomics, Beth Israel Deaconess Medical Center, BGI Americas, BigOmics Analytics, Bill and Melinda Gates Foundation, Bio-Medical Science, Bio-Rad Laboratories, Bio-Techne, BioBright, Biocept, Biodesix, BioIntelliSense, BioLegend, BioLizard, BioMap, BioMarin Pharmaceutical, BiomX, BioNano Genomics, Biosplice, Bioz, bitBiome, Blockchain Global, Bluebee, Blue Cross Blue Shield Association, Blueprint Genetics, BlueRock Therapeutics, Boca Biolistics, Boehringer Ingelheim, BostonGene, Breakthrough Genomics, Brigham and Women's Hospital, Bristol-Myers Squibb, Broad Clinical Labs, Broad Institute, Buhler, Burning Rock, C2i Genomics, Calyxt, Cambridge Cancer Genomics, CAMP4 Therapeutics, Canadian Council, Cancer Research Horizons, Cancer Research UK, Canopy Biosciences, CareDx, Caribou Biosciences, Caris Life Sciences, Cartana, Cartography Biosciences, Celemics, Cell and Gene Therapy Catapult, CellChorus, Cellgen Diagnostics, Cell Mogrify, Cellworks, Celmatix, Celsius Therapeutics, Center for Aquaculture Technologies, Center for Forensic Science Research & Education, Centers for Disease Control and Prevention, Centogene, Centre for Research in Agricultural Genomics, Centre Leon Berard, Cepheid, Cerba Research, CGA 369, Chan Zuckerberg Initiative, Charcot-Marie-Tooth Association, Charite Universitatsmedizin Berlin, Children's Hospital Boston, Children's Hospital of Philadelphia, Children's Medical Research Institute, Chinese Academy of Agricultural Science, Christian Doppler Research Association, Chroma Medicine, Chugai Pharmaceutical, CHU Sainte-Justine, Circuit Clinical, Cleveland Clinic, Clover Therapeutics, CMT Research Foundation, Coastar Therapeutics, Codexis, Cofactor Genomics, Colorado Center for Personalized Medicine, Columbia University, Columbia University Medical Center, CombiGene, Complete Genomics, ConcertAI, Concr, Congenica, Contextual Genomics, CoreBiome, Coriell Life Sciences, Corteva Agriscience, CosmosID, Covaris, Crohn's and Colitis Foundation of America, Crown Bioscience, CSI Laboratories, Culmination Bio, CureMatch, Curetis, CureVac, Curio Genomics, Cyclica, CYTOVIA Therapeutics, Cytox, Daiichi Sankyo, Dana-Farber Cancer Institute, Dante Genomics, Dante Labs, DaRui Biotech, Data Tecnica International, Datavant, Decipher Biosciences, Decode Health, Deep Genomics, DefiniGEN, Denali Therapeutics, Dendreon, Department of Health - Abu Dhabi, Department of Veterans Affairs, Desktop Genetics, DestiNA Genomics, Devyser Diagnostics, Discovery Life Sciences, Diversigen, DNAnexus, DNA Script, Dolomite Bio, Dovetail Genomics, DrChrono, Duke-NUS Graduate Medical School Singapore, Duke University Health System, DuPont, DuPont Pioneer, e-NIOS, Eagle Genomics, Edico Genome, Editas Medicine, Eisai, Element Biosciences, Elevation Oncology, Eli Lilly, EMBRAPA, EMD Serono, Emedgene, Emendo Biotherapeutics, EncrypGen, Endocanna Health, ENPICOM, Ensoma, Enzyvant Science, Epic Sciences, Epicypher, Epilepsy Society, Epivax, Erasmus University Medical Center, ERS Genomics, Euformatics, Eureka Eurostars, Eurofins Scientific, European Equity Partners, European Organization for Research and Treatment of Cancer, European Union, Evonetix, Evotec, Evvy, Exact Sciences, F1 Oncology, Fabric Genomics, Factorial Biotechnologies, Factorial Diagnostics, Falco, FDNA, Ferring Pharmaceuticals, FinnGen, First Genetics JCS, Flare Therapeutics, Flatiron Health, Fluent BioSciences, FMC, Fortis Life Sciences, Foundation for Innovative New Diagnostics, Foundation Medicine, Fox Chase Cancer Center, Fred Hutchinson Cancer Research Center, Freenome, Front Range Biosciences, Fujitsu Laboratories, Fulgent Genetics, Fulgent Pharma, Fusion Genomics, G+FLAS Life Sciences, G42 Healthcare, Ganymede Bio, GC Genome, GEDmatch, Geisel School of Medicine at Dartmouth, Gemini Therapeutics, Gencove, GeneCentric Therapeutics, Genective, GeneDX, GenEmbryomics, Genentech, General Genomics, Geneseeq, Genetica, Genetic Technologies, Genetiks, Genetron Health, Genewiz, Geneyx, Genialis, Genolution, Genome BC, Genome Canada, GenomeDx, Genome Insight, Genome Medical, Genomenon, Genome Prairie, Genomic Biopharma, Genomics, Genomics England, Genomic Testing Cooperative, Genomic Vision, Genomind, Genomoncology, Genoox, GenoScreen, Genosity, GenScript Biotech, Genspace, Genuity Science, GenXys, Genzeva, Georgetown University, German Cancer Research Center, Gilead Sciences, Ginkgo BioWorks, Global Genomics Group, Google, Government of Canada, Gretel, GSK, Guardant Health, Gusto Global, H3 Biomedicine, Hackensack Meridian Health, Hamilton Company, Hamilton Robotics, Hanmi Pharmaceutical, Hannover Medical School, HaploX, Harvard Medical School, Harvard University, Heligenics, Helix, Henry Ford Health System, HepaTx, Hereditary Neuropathy Foundation, Hitachi High-Technologies Corporation, Horizon Discovery, Hospital for Sick Children, Hospital for Special Surgery, HTG Molecular Diagnostics, Hudson-Alpha Institute for Biotechnology, Human Cell Atlas, Hummingbird Bioscience, IBM, IBM Watson Health, Icahn School of Medicine at Mount Sinai, IDbyDNA, Illumina, ILUM Health Solutions, IMBdx, Immunai, Immunex, IncellDx, Incyte, Indiana University, Indivumed, IndyGeneUS AI, Inivata, Innoplexus, Innovate UK, Innovative Genomics Initiative (IGI), Inocras, Inovio Pharmaceuticals, Inserm, Insitro, InSphero, Institut Gustave Roussy, Integra, Integra Biosciences, Integrated Biosciences, Integrated DNA Technologies, Intel, Intellia Therapeutics, Intelligence Advanced Research Projects Activity (IARPA), Intelliseq, Intermountain Precision Genomics, International Center for Genetic Engineering and Biotechnology, International Myeloma Foundation, International Rice Research Institute, InterSystems, inviCRO, Invitae, InVivoScribe, Ionis Pharmaceuticals, IQVIA, iReceptor Plus, Israeli National Authority for Technological Innovation, Jackson Laboratory, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, JASE Health, Jeffrey Modell Foundation, Johns Hopkins University, Johnson & Johnson Innovation, Jumpcode Genomics, Kartos Therapeutics, KEW, Keygene, King Abdullah International Research Center, KingMed Diagnostics, Kiromic Biopharma, Komodo Health, Konica Minolta Precision Medicine, KPMG, Kura Oncology, Kytopen, Laboratorio Curie, Laboratory Corporation of America, La Jolla Institute for Allergy & Immunology, Lantern Pharma, Latvian Institute of Organic Synthesis, Lee Moffitt Cancer Center, Lenovo, Lesaffre, Les Laboratoires Servier, Lexent Bio, LGC, LifeLabs Medical Laboratory Services, LifeMap Sciences, LifeOmic, Life Raft Group, Linus Biotechnology, LMU University Hospital Munich, Locus Biosciences, LogicBio Therapeutics, Longenesis, Lonza, Loxo Oncology, Lunaphore, Lung Cancer Research Foundation, M42, Macrogen, Mainz Biomed, MapKure, Massachusetts General Hospital, Massachusetts Institute of Technology, Mass General Brigham, Massive Bio, Mayo Clinic, MD Anderson Cancer Center, Medaffcon, Medgenics, MedGenome, Medical College of Wisconsin, Medical University of Graz, Medicinal Genomics, MEDiC Life Sciences, MedStar Health Research Institute (MHRI), Meharry Medical College, Meiogenix, Memorial Sloan Kettering Cancer Center, Menarini Silicon Biosystems, Merck and Co, Merck KGaA, Merus, Metabolon, MGI Pharma, MGI Tech, Michael J Fox Foundation, Michelson Center, Microba Life Sciences, Microbiotica, MicroGenDX, MicroMGx, Micronoma, Microsoft, MiLaboratories, Miltenyi Biotec, MindImmune Therapeutics, Miroculus, Mirus Bio, Mission Bio, Moderna, Molbio Diagnostics, Molecular Health, Moleculera Labs, Monsanto, MorphoSys, Moss Genomics, MP Group, Multiplex Genomics, Muscular Dystrophy Association, Myriad Genetics, Myrtelle, MyVytalics, NABsys, Nalagenetics, Namocell, Nanite, Nankai Hospital, NanoCellect Biomedica, NanoString Technologies, Nashville Biosciences, Natera, National Cancer Center, National Cancer Center of Japan, National Cancer Centre Singapore, National Cancer Institute, National Health Service, National Human Genome Research Institute, National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development, National Institute of General Medical Sciences, National Institutes of Health, Navican, Nebraska Medicine, Nebula Genomics, NEC, Negen, Neochromosome, Neogen, Neogenomics, NeraCare, Netherlands Cancer Institute, Neuron23, New England Biolabs, NewStem, New York Genome Center (NYGC), New York State Department of Health, New York University School of Medicine, Next Gen Diagnostics, NGeneBio, NMI Natural and Medical Sciences Institute, Nonacus, Normunity, North Med, Novartis, NovellusDx, Novigenix, Novogene, Novo Nordisk, Nrgene, Nucleix, NuProbe, Nvidia, NYU Grossman School of Medicine for Preclinical and Clinical Research, Ochre Bio, Octant, Ohio State University, Olink Bioscience, OMAPiX, Omico, Omniome, OncoDNA, Oncompass Medicine, Oncoshot, OncXerna Therapeutics, One Biosciences, One Codex, ONK Therapeutics, Onramp Bioinformatics, Ontario Institute for Cancer Research, OpenBench, Open Medicine Institute, Opentrons Labworks, OpGen, Orchid Cellmark, Oregon Health Sciences University, OrigiMed, Origin Agritech, Oryzon, Ovation, Owkin, Oxford Biodynamics, Oxford Nanopore Technologies, Ozette Technologies, Pacific Biosciences, Paige, Pairwise Plants, Pancreatic Cancer Action Network, Pancreatic Cancer Collective, Pancreatic Cancer Early Detection Consortium, Paragon Genomics, Parexel, Parse Biosciences, Partek, Path BioAnalytics, PathGroup, Pennsylvania State University, PerkinElmer, Personal Genome Diagnostics, Personalis, PetaGene, Pfizer, Pharnext, Phase Genomics, Pierian, PierianDx, Pillar Biosciences, Pioneer Hi-Bred, PlumCare, Pluristem Therapeutics, Pluristyx, PPD, Precision BioSciences, Precision NanoSystems, Predicine, Premier Inc, Prenetics, Prepaire Labs, Prescient Medical, Princess Margaret Hospital, Progenesis, Progknowse, Project 8p Foundation, Promega, Prophase Labs, Proteic Bioscience, Proteona, Proteus Genomics, Pryzm Health, Q2 Solutions, Qatar Foundation, QIAGEN, Quanterix, QuantumDx, Quest Diagnostics, rAAVen Therapeutics, Rady Children's Institute for Genomic Medicine, Realm IDx, Recombia Biosciences, Regeneron Genetics Center, Regeneron Pharmaceuticals, Repertoire Genesis, Replicate Bioscience, Resilient Biotics, Resolve Biosciences, Reveal Genomics, RevolKa, Revvity, Rice University, RIKEN Center for Integrative Medical Sciences, RIKEN Research Institute, Ripe Technology, Roche, Roche Diagnostics, Roivant Sciences, Royal Philips Electronics, RTI International, Rutgers University, Ryailti, S2 Genomics, SalioGen Therapeutics, Sana Biotechnology, Sangamo Therapeutics, Sanofi, Saol Therapeutics, Saphetor, Scale Biosciences, Scarab Genomics, Scipher Medicine, Scripps Translational Science Institute, Secarna Pharmaceuticals, Sema4, Sentieon, SenzaGen, Seoul National University, Seqster, Sequentify, SeQure Dx, SeqWell, Seracare Life Sciences, Serotiny, Seven Bridges Genomics, Shanghai ChemPartner, Shionogi, Shivom, Singleron Biotechnologies, Singular Genomics Systems, Sohm, SomaLogic, SOPHiA Genetics, Spanish National Cancer Research Centre, Spatial Genomics, Spectrum Pharmaceuticals, SPT Labtech, Stanford University, Stanford University School of Medicine, Stem Genomics, Stem Pharm, Stockholm University, Strata Oncology, Streck Laboratories, Structural Genomics Consortium, Sumitomo Dainippon Pharma, Sumitovant Biopharma, Summit Pharmaceuticals, Sunnybrook Research Institute, SunTerra Biotechnology, Susan G. Komen for the Cure, Swift Biosciences, Swiss Institute of Bioinformatics (SIB), Syngenta, Synthego, Syros Pharmaceuticals, Sysmex, Sysmex Inostics, Tagomics, Taiwan Precision Medicine Initiative, Takara Bio, Takeda Pharmaceutical, Takeda Ventures, Tango Therapeutics, Tavros Therapeutics, Taysha Gene Therapies, Tecan, Tempus, Tesis Biosciences, Tessera Therapeutics, The New York Stem Cell Foundation, The Parker Institute For Cancer Immunotherapy, Theraly Fibrosis, Thermo Fisher Scientific, The Silverstein Foundation for Parkinson's, Thomas Jefferson University, Tokyo Medical and Dental University, Tow Foundation, TP Therapeutics, Trajan Scientific and Medical, Transgene, Translational Drug Development, Translational Genomics Research Institute, Transnetyx, Transomic Technologies, TwinStrand Biosciences, Twinstrand Therapeutics, Twist Bioscience, Ultima Genomics, Ultivue, Umoja Biopharma, Univeristy of Durham, University College London, University Health Network, University Hospital Heidelberg, University of Adelaide, University of Alabama at Birmingham, University of British Columbia, University of Buffalo, University of California, San Diego, University of California Berkeley, University of California Irvine, University of California Los Angeles, University of California San Francisco, University of California Santa Cruz, University of Colorado Denver, University of Florida, University of Greifswald, University of Hong Kong, University of Illinois, University of Illinois Urbana-Champaign, University of Lausanne, University of Manchester, University of Massachusetts, University of Miami, University of Minnesota, University of Ottowa, University of Oxford, University of Pennsylvania, University of Pittsburgh, University of Rochester Medical Center, University of Rostock, University of Sydney, University of Tokyo, University of Tubingen, University of Verona, University of Washington, University of Wisconsin, University of Wisconsin Carbone Cancer Center (UWCCC), US Oncology, Variant Bio, Veracyte, Verge Genomics, Veritas, Veritas Genetics, Verogen, Vertex Pharmaceuticals, Victoria University, VieCure, Vir Biotechnology, Vitaccess, Vizgen, Volta Labs, Wasatch BioLabs, Washington University in St Louis, Watchmaker Genomics, Weihai Weigao Medical Devices, Weill Cornell Medical College, Wellcome Trust Sanger Institute, Western Digital, Whitehead Institute, WuXi NextCODE Genomics, Xcell Biosciences, Xencor, Xpress Technologies, Yale School of Medicine, Yale University, Yeda Research and Development Company, Yield10 Bioscience, ZAI Laboratory, Zymergen, Zymo Research

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.